Concepedia

Xianglin Wu

XW

Statistics

Publications

15

Citations

1.5K

H-Index

14

Active since

2001

Affiliations

Mayo Clinic(Current)

Mayo Clinic in Florida

Mayo Clinic in Arizona

Radiation Oncology Associates

WinnMed

Xianglin Wu is an author at Mayo Clinic specializing in life sciences, oncology, and molecular biology.

Publications per year

2001–2023

15

Publications

15

MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways

Zhenkun Lou, Katherine Minter‐Dykhouse, Xianglin Wu et al. · Nature · 2003 · 335 citations

, , +12

The Tamoxifen Metabolite, Endoxifen, Is a Potent Antiestrogen that Targets Estrogen Receptor α for Degradation in Breast Cancer Cells

Xianglin Wu, John R. Hawse, Malayannan Subramaniam et al. · Cancer Research · 2009 · 225 citations · Full text

, , +17

A DNA Damage-Regulated BRCT-Containing Protein, TopBP1, Is Required for Cell Survival

Kazuhiko Yamane, Xianglin Wu, Junjie Chen · Molecular and Cellular Biology · 2002 · 184 citations

, , +17

Characterization of Tumor-associated Chk2 Mutations

Xianglin Wu, Shelley R. Webster, Junjie Chen · Journal of Biological Chemistry · 2001 · 176 citations · Full text

, , +16

Threonine 68 of Chk2 Is Phosphorylated at Sites of DNA Strand Breaks

Irene M. Ward, Xianglin Wu, Junjie Chen · Journal of Biological Chemistry · 2001 · 108 citations · Full text

, , +16

1–5 of 15